Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 11,788 shares at $61.36 ($723K) on 2010-05-05, disclosed to the SEC on 2010-05-07.
Open-market sale of $723k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.36 | 9,637 | $591K | 81.7% |
| 2 | $61.40 | 2,151 | $132K | 18.3% |
| Total | $61.37 avg | 11,788 | $723K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |